West Harlem’s Volastra Therapeutics Appoints Charles Hugh-Jones As New CEO
Volastra Therapeutics, a biotechnology company developing novel therapies to treat and prevent the formation of metastatic disease, has named Charles Hugh-Jones, MD, FRCP, as its Chief Executive Officer. Become a Harlem Insider! Sign-Up for our Newsletter *Select list(s) to subscribe toHarlem World Magazine Example: Yes, I would like to receive emails from Harlem World Magazine.…